“Deal Making in Pharmaceuticals & Biotechnology” (Argyle Executive Forum 2012 Leadership in Pharmaceuticals & Biotechnology)
June 14, 2012
Adam Golden, Partner and Co-Chair of the Corporate Department, will moderate the panel “Deal Making in Pharmaceuticals & Biotechnology” at the Argyle Executive Forum’s 2012 Leadership in Pharmaceuticals & Biotechnology meeting on June 14, 2012 in New York. The panel will discuss current market information and deal drivers, recent trends in deal structuring, the incorporation of risk sharing into transactions, determining which deal structure will lead to the greatest return on investment and key components to consider in valuing a life science asset.External Link: For more information on this program, please click here. (link will open in a new window)